The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...
Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...
Inhalon Biopharma, Inc. (Inhalon), a clinical-stage company advancing a first-in-class inhaled antibody platform for treating acute respiratory infections (ARI), today announced the completion of ...
Alexion Pharmaceuticals v Amgen (UPC_Coa-405/2024) and Alexion Pharmaceuticals v Samsung Bioepis NL BV (UPC_CoA-402/2024); December 20, 2024.
Vetigenics, a clinical-stage animal health biotechnology company specializing in antibody therapeutics for pets, announces significant progress over the past year, including closing a $6 million seed ...
This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...
4d
Fapon's CLIA and biochemistry product lines exemplify its expertise in One-stop IVD solutions. Its CLIA One-stop solution includes the Shine i-series open-system CLIA analyzers for low- to ...
During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get ...
InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.
Telephone participation in the webinar can be arranged by contacting Microbix or Adelaide Capital at the contact numbers provided at the end of this news release. A replay of the webinar will also be ...
Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix® ), a life sciences innovator, manufacturer, and exporter, announces that it has received C$ 2.4 million in new equity capital from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback